In heterogeneous catalysis, the catalyst is in a different phase from the reactants. Safety of 4-(4-((2,4-Dioxothiazolidin-5-ylidene)methyl)-2-methoxyphenoxy)-3-(trifluoromethyl)benzonitrile, At least one of the reactants interacts with the solid surface in a physical process called adsorption in such a way. 1055361-35-7, name is 4-(4-((2,4-Dioxothiazolidin-5-ylidene)methyl)-2-methoxyphenoxy)-3-(trifluoromethyl)benzonitrile. In an article£¬Which mentioned a new discovery about 1055361-35-7
PYRIDINE COMPOUNDS AND METHODS OF THEIR USE
Novel pyridine compounds, pharmaceutical compositions containing the pyridine compounds, and methods of their pharmaceutical use are disclosed. In certain embodiments, the pyridine compounds are agonists and/or ligands of cannabinoid receptors and may be useful, inter alia, for treating and/or preventing pain, gastrointestinal disorders, inflammation, auto-immune diseases, ischemic conditions, immune-related disorders, hypertension, neurological disorders, and neurodegenerative diseases, for providing cardioprotection against ischemic and reperfusion effects, for inducing apoptosis in malignant cells, for inhibiting mechanical hyperalgesia associated with nerve injury, and as an appetite stimulant.
I hope this article can help some friends in scientific research. I am very proud of our efforts over the past few months and hope to 1055361-35-7, help many people in the next few years.Safety of 4-(4-((2,4-Dioxothiazolidin-5-ylidene)methyl)-2-methoxyphenoxy)-3-(trifluoromethyl)benzonitrile
Reference£º
Quinuclidine – Wikipedia,
Quinuclidine | C7H843N | ChemSpider